This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_UTERUS_NAS_EXALLC for full statistics.
Malignant neoplasm of uterus, part unspecified
C3_UTERUS_NAS
uterine neoplasm: ['Tumors of the UTERUS.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
26 |
4. Check minimum number of eventsNone |
26 |
5. Include endpointsNone |
26 |
6. Filter based on genotype QC (FinnGen only) |
26 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of uterus, part unspecified
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 26 | 26 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 61.12 | 61.12 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
6
12.45
3.70
1.8
1.2
pmol/l
98.8
75.5
—
6
6
(40758558) Short blood count panel - Blood
11
46
3.41
2.21
8.5
7.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
11
5.33
2.04
4.0
8.5
%
95.9
93.8
—
5
11
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
18
4.00
1.87
4.3
6.8
g/l
105.5
114.6
—
6
18
(3007853) Bacteria identified in Skin by Aerobe culture
7
25
3.44
1.80
1.1
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
8
33
3.04
1.71
2.8
3.3
%
92.9
92.4
—
8
33
(3002256) Pathology report gross observation
5
17
3.38
1.43
1.6
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
15
91
2.53
1.42
4.4
4.6
mmol/l
1.2
1.2
0.46
15
79
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
79
2.29
1.16
3.1
3.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
43
1.85
0.74
3.9
5.2
—
—
—
0
0
(3015736) pH of Urine
12
83
1.83
0.68
3.3
5.0
—
—
—
0
0
(3044889) 12 lead EKG panel
17
133
1.80
0.66
3.6
3.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
17
134
1.77
0.66
6.2
6.6
—
572.8
—
0
6
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
9
60
1.76
0.64
2.3
2.2
u/l
68.8
48.5
—
9
51
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
20
0.00
0.63
0.0
4.4
—
32.5
—
0
12
(3003694) ABO and Rh group [Type] in Blood
7
45
1.76
0.55
1.7
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
46
1.71
0.54
2.9
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
17
0.00
0.42
0.0
5.2
—
—
—
0
0
(3019225) pH of Specimen
0
18
0.00
0.41
0.0
3.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
10
74
1.57
0.40
3.1
1.7
u/l
107.1
201.0
—
10
68
(3044640) Blood type and Crossmatch panel - Blood
8
61
1.45
0.33
2.9
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
65
1.33
0.31
3.6
4.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
19
169
1.46
0.29
4.2
4.5
mmol/l
4.7
4.5
0.29
19
155
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
12
142
0.71
0.27
5.3
4.1
pmol/l
15.6
15.0
0.32
12
121
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
11
89
1.41
0.26
2.4
4.8
ng/l
22.8
96.6
—
6
64
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11
89
1.41
0.26
1.7
2.1
pmol/l
106.8
96.0
—
5
44
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
90
1.39
0.24
6.7
3.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
6
47
1.36
0.23
2.3
3.2
mg/l
6300.9
12.6
—
6
33
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13
111
1.34
0.21
6.0
5.5
umol/l
10.1
10.0
0.02
13
101
(42870588) Differential panel, method unspecified - Blood
7
56
1.34
0.21
3.0
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
7
58
1.28
0.20
3.3
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6
77
0.71
0.19
1.7
4.1
ng/l
622.8
2202.0
—
6
66
(40761511) CBC panel - Blood by Automated count
20
182
1.43
0.19
19.5
17.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
9
77
1.26
0.18
2.4
4.2
%
61.1
57.8
—
9
72
(3002030) Lymphocytes/100 leukocytes in Blood
9
78
1.23
0.18
3.1
4.3
%
23.3
26.2
—
9
71
(3026008) Bacteria identified in Urine by Culture
10
85
1.29
0.15
4.8
4.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
88
1.22
0.10
4.9
5.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
5
59
0.81
0.09
2.2
2.0
nmol/l
1485.2
1259.9
—
5
45
(3020564) Creatinine [Moles/volume] in Serum or Plasma
20
190
1.23
0.09
25.0
20.6
umol/l
85.0
74.5
0.72
20
190
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
20
190
1.23
0.09
11.3
10.3
u/l
22.1
21.5
0.05
20
181
(3022096) Basophils/100 leukocytes in Blood
8
74
1.12
0.09
3.4
4.1
%
0.7
0.6
—
8
69
(40768804) Tissue Pathology biopsy report
9
82
1.15
0.08
2.1
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
9
83
1.13
0.08
3.3
4.1
e9/l
0.0
0.0
—
9
77
(3001604) Monocytes [#/volume] in Blood
9
84
1.11
0.08
3.3
4.0
e9/l
0.6
0.6
—
9
77
(3013115) Eosinophils [#/volume] in Blood
10
89
1.20
0.08
3.1
4.1
e9/l
0.1
0.2
—
10
84
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
8
90
0.84
0.08
2.6
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
14
135
1.08
0.00
5.6
5.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
20
196
1.09
0.00
25.0
21.0
mmol/l
3.8
4.0
4.02
20
188
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
1.4
—
0
6
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
20
196
1.09
0.00
30.9
25.6
e9/l
256.2
258.1
0.04
20
189
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5
56
0.87
0.00
1.6
3.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
9
87
1.05
0.00
3.6
4.0
e9/l
1.6
1.8
—
9
80
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.5
—
6.2
—
0
6
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
7
72
0.96
0.00
8.6
9.3
e9/l
0.0
0.0
—
7
66
(3013512) EKG study
5
58
0.83
0.00
2.8
4.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
9
0.00
0.00
0.0
7.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
18
174
1.11
0.00
4.6
5.0
mu/l
1.8
2.0
0.57
18
153
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
7
69
1.02
0.00
3.6
4.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
20
195
1.11
0.00
24.9
21.0
mmol/l
139.3
139.4
0.03
20
186
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
0
8
0.00
-0.00
0.0
2.5
—
3.5
—
0
8
(3045414) Leukocytes [Presence] in Urine
0
8
0.00
-0.00
0.0
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
3.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_UTERUS_NAS – Malignant neoplasm of uterus, part unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).